Derma Sciences (NSDQ:DSCI) said last week that it paid $13.3 million for Medihoney, on the same day that Integra LifeSciences (NSDQ:IART) agreed to pay nearly $200 million for the tissue regeneration company. Prior to the acquisition, Derma Sciences held the exclusive global license for the Comvita-owned Medihoney brand and patents. Medihoney is eligible to receive an additional […]
Wound Care
Integra LifeSciences to acquire Derma Sciences for $200m
Integra LifeSciences (NSDQ:IART) said yesterday that it agreed to pay nearly $200 million for Derma Sciences (NSDQ:DSCI) and its line of wound care products. The $7-per-share deal includes a line of regenerative allograft products derived from human placental tissue that Derma Sciences acquired when it paid nearly $80 million for BioD last year. Integra also agreed to […]
Apligraf cell therapy changes genomic profile of chronic wound
Organogenesis Inc. said yesterday that its wound-healing cell therapy Apligraf is the 1st of its kind to significantly change the genomic profile of a treated chronic wound. The claim was supported by new research done at the University of Miami and published in the journal Science Translational Medicine. The team applied Apligraf to a chronic venous leg […]
NanoVibronix lands Health Canada nod for patch-based wound healing device
NanoVibronix (NSDQ:NVBXU) said today that it won approval from Health Canada to sell its WoundShield device in Canada. The Elmsford, N.Y.-based company has also won CE mark approval for the device in the European Union. The WoundShield system is a patch-based ultrasound device that increases local capillary perfusion and tissue oxygenation to facilitate soft tissue […]
MiMedx touts Aetna reimbursement win for EpiFix implant
MiMedx (NSDQ:MDXG) said today that it won coverage from Aetna Inc. for its EpiFix allograft effective December 23rd. The insurance company classified EpiFix as “medically necessary” for the treatment of partial and full-thickness neuropathic diabetic foot ulcers when used in combination with standard diabetic ulcer care. The non-viable cellular amniotic membrane allograft helps to regenerate soft […]
Sweden’s SCA buys BSN Medical for $2.8B
Swedish hygiene and forest products maker Svenska Cellulosa Aktiebolaget won out over private equity rivals in the race for BSN Medical, with SCA agreeing to pay nearly $2.82 billion (€2.7 billion) for the wound care and orthopedics firm. Luxembourg-based BSN launched in 2001 as a joint venture between Germany’s Beiersdorf and Smith & Nephew (NYSE:SNN). Swedish PE shop EQT bought BSN […]
Acelity spikes $1B IPO
Wound care and regenerative medicine company Acelity yesterday spiked an initial public offering that could have fetched as much as $1 billion. Acelity, formerly Kinetic Concepts Inc., was acquired for $6.1 billion by Apax Partners and a pair of Canadian pension funds in a leveraged buyout in November 2011. The company, which makes wound care products, later […]
Abyrx raises $10m, inks soft-tissue adhesive deal with Bezwada Biomedical
Abyrx said today it raised $10 million in a new equity financing round and expanded its exclusive, global license agreement with Bezwada Biomedical to include the development and production of Bezwada’s soft-tissue adhesive tech. Funds in the $10 million round came from Canaan Partners, MedEdge, BB Biotech Ventures and members of the company’s executive team, with […]
Usnic acid electrospun fibers demonstrate antibacterial properties
Researchers from the Institute of Materials Science in Juazeiro, Brazil have reported on the antibacterial properties of usnic acid, a strong lichen metabolite, encapsulated in electrospun fibers. The team’s work was published in Recent Patents on Nanotechnology. Usnic acid has been used in commercial products, such as creams, toothpastes and sunscreen, due to their antiviral, animicrobial […]
InGeneron inks collaboration with German Accelerator Life Sciences
InGeneron said today that it landed a collaboration with the German Accelerator Life Sciences program, establishing an additional U.S. presence in Cambridge, Mass. The initiative is supported by the German Federal Ministry for Economic Affairs & Energy. The GALS program will provide InGeneron with a group of mentors to help leverage its network within the […]
Actamax touts clinical data for sprayable adhesion barrier device
Actamax Surgical Materials, a DSM-DuPont joint venture, touted data from a 12-month clinical follow-up study evaluating the effects of its biocompatible, resorbable adhesion barrier device. The results were presented this week at the 45th Global Congress on Minimally Invasive Gynecology in Orlando, Fla. Adhesions, excessive scar tissue that can form between adjacent internal tissues, are […]